Market Forecasts for Immuno-Oncology Diagnostics 2023: Outcome Potential and Companion Diagnostics Driving Growth
January 16, 2023 07:58 ET
|
Research and Markets
Dublin, Jan. 16, 2023 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics Including Executive/Consultant Guides and Customized Forecasting/Analysis. 2023 to 2027" report has...
Testicular Cancer - Global Pipeline Insights, 2022
January 11, 2023 07:43 ET
|
Research and Markets
Dublin, Jan. 11, 2023 (GLOBE NEWSWIRE) -- The "Testicular Cancer - Pipeline Insights, 2022" clinical trials has been added to ResearchAndMarkets.com's offering.This "Testicular Cancer - Pipeline...
Global Hemoglobinopathies Market Report 2022: Featuring Abbott, Sanofi, Danaher, Pfizer, Merck & More
January 10, 2023 10:18 ET
|
Research and Markets
Dublin, Jan. 10, 2023 (GLOBE NEWSWIRE) -- The "Global Hemoglobinopathies Market Size, Share & Industry Trends Analysis Report By Type (Thalassemia, Sickle Cell Disease), By Distribution Channel,...
Antibody Drug Conjugate Global Market Report 2023: 190 Active Clinical Trials Bodes Well for Acceptance and Growth
January 04, 2023 07:28 ET
|
Research and Markets
Dublin, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugate Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and...
North America Glycomic Therapeutics Market Report 2022: Increasing Research and Development Bolsters Sector Growth
December 30, 2022 07:33 ET
|
Research and Markets
Dublin, Dec. 30, 2022 (GLOBE NEWSWIRE) -- The "North America Glycomic Therapeutics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - Class, Structures, Indications, Mode of Action"...
Growing Demand for Animal Free Recombinant Cell Culture Supplements and Increase in Investments in R&D are Boosting Growth
December 29, 2022 07:23 ET
|
Research and Markets
Dublin, Dec. 29, 2022 (GLOBE NEWSWIRE) -- The "Recombinant Cell Culture Supplements Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product, By...
Cancer Immunotherapy Global Market Report 2022: Spike in R&D Efforts for the Creation of Novel Oncology Treatment Bolsters 7.5% Annual Growth
December 29, 2022 06:13 ET
|
Research and Markets
Dublin, Dec. 29, 2022 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Market by Product, Distribution Channel, Application, End Use, and by Region - Global Forecast to 2022-2033" report has been added...
2022 TYSABRI (Natalizumab) Report: A Recombinant Humanized IgG4 Monoclonal Antibody Produced in Murine Myeloma Cells - Drug Insight and Market Forecasts to 2032
December 22, 2022 06:03 ET
|
Research and Markets
Dublin, Dec. 22, 2022 (GLOBE NEWSWIRE) -- The "TYSABRI (Natalizumab), Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering."TYSABRI (Natalizumab),...
Monoclonal Antibody Discovery and Analysis market is projected to grow at a CAGR of 9.0% by 2032: Visiongain Reports Ltd
December 19, 2022 12:47 ET
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Monoclonal Antibody Discovery and Analysis 2022-2032. It includes profiles of Monoclonal Antibody Discovery and Analysis and Forecasts Market Segment by...
Sepsis Drug Pipeline Research Report 2022: Comprehensive Insights about 40+ Companies and 40+ Pipeline Drugs
December 15, 2022 08:13 ET
|
Research and Markets
Dublin, Dec. 15, 2022 (GLOBE NEWSWIRE) -- The "Sepsis - Pipeline Insight, 2022" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about...